Kevin R. Loughlin, MD, MBA, Consulting Editor

In 2017, the Sidney Kimmel Cancer Center of Thomas Jefferson University held the First International Consensus Conference on The Role of Genetic Testing for Inherited Prostate Cancer Risk, which was organized by Leonard G. Gomella, Karen E. Knudsen, and Veda N. Giri. 1 Giri V.N. Knudsen K.E. Kelly W.K. et al. Role of genetic testing for inherited prostate cancer risk: Philadelphia Prostate Cancer Conference 2017.

J Clin Oncol. 2018; 36: 414-424

This was followed by the 2019 Philadelphia Prostate Cancer Consensus Program: Implementation of Genetic Testing for Prostate Cancer by the same group. 2 Giri V.N. Knudsen K.E. Kelly W.K. et al. Implementation of germline testing for prostate cancer: Philadelphia Prostate Cancer Consensus Conference 2019.

J Clin Oncol. 2020; 38: 2798-2811

These conferences, which were multidisciplinary and attended by national and international experts, were hugely successful. Future biennial meetings are being planned, and as many other successful endeavors, it is now referred to in its shortened form by prostate experts simply as the “Philadelphia Conference.”